Vrielink H - Search Results

1

Vrielink H. Vrielink H. Transfus Apher Sci. 2023 Apr;62(2):103663. doi: 10.1016/j.transci.2023.103663. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36872124 No abstract available.

2

Apheresis machines variably overestimate mononuclear cell collection volume.

Deeren D, Neyrinck M, Vrielink H. Deeren D, et al. Among authors: vrielink h. J Clin Apher. 2020 Aug;35(4):290-293. doi: 10.1002/jca.21789. Epub 2020 May 8. J Clin Apher. 2020. PMID: 32384186

3

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs.

Vrielink H, Zaaijer HL, Reesink HW, van der Poel CL, Cuypers HT, Lelie PN. Vrielink H, et al. Vox Sang. 1995;69(1):14-7. doi: 10.1111/j.1423-0410.1995.tb00341.x. Vox Sang. 1995. PMID: 7483486 Clinical Trial.

4

Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.

Vrielink H, Sisay Y, Reesink HW, Woerdeman M, Winkel C, de Leeuw SJ, Lelie PN, van der Poel CL. Vrielink H, et al. Transfus Med. 1995 Jun;5(2):135-7. doi: 10.1111/j.1365-3148.1995.tb00201.x. Transfus Med. 1995. PMID: 7655577

5

[Brain infarction due to polycythemia as first indication of renal cell carcinoma].

Beckers EA, González García FN, Vrielink H, Sanquin Bloedbank. Beckers EA, et al. Among authors: vrielink h. Ned Tijdschr Geneeskd. 2006 Jul 22;150(29):1642; author reply 1642. Ned Tijdschr Geneeskd. 2006. PMID: 16901071 Dutch. No abstract available.

6

Look-back study of infectivity of anti-HCV ELISA-positive blood components.

Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, Lelie PN, van Oers MH. Vrielink H, et al. Lancet. 1995 Jan 14;345(8942):95-6. doi: 10.1016/s0140-6736(95)90063-2. Lancet. 1995. PMID: 7815889

7

Apheresis training for nurses and physicians around the World.

Neyrinck M, Vrielink H; Joint Task Force for Apheresis Education and Certification. Neyrinck M, et al. Among authors: vrielink h. J Clin Apher. 2015 Feb;30(1):32-7. doi: 10.1002/jca.21345. Epub 2014 Jul 8. J Clin Apher. 2015. PMID: 25044617

8

Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic.

Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee CK, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C. Wendel S, et al. Among authors: vrielink h. Vox Sang. 2021 Sep;116(8):872-879. doi: 10.1111/vox.13096. Epub 2021 Mar 27. Vox Sang. 2021. PMID: 33772791 Free PMC article.

9

Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.

Vrielink H, van der Poel CL, Reesink HW. Vrielink H, et al. Vox Sang. 1995;68(4):251-2. doi: 10.1111/j.1423-0410.1995.tb02584.x. Vox Sang. 1995. PMID: 7660648 No abstract available.

10

Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.

Weinreich SS, Remmerswaal EB, Laport R, van Rhenen DJ, Rombout-Sastrienkova E, Smit Sibinga CT, Vrielink H, Boog CJ. Weinreich SS, et al. Among authors: vrielink h. Vox Sang. 2000;79(2):83-6. doi: 10.1159/000031217. Vox Sang. 2000. PMID: 11054045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page